{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:53:50Z","timestamp":1780458830393,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Momentum garnt","award":["LP-95021"],"award-info":[{"award-number":["LP-95021"]}]},{"DOI":"10.13039\/501100011019","name":"NKFIH","doi-asserted-by":"crossref","award":["NVKP_16-1-2016-0004"],"award-info":[{"award-number":["NVKP_16-1-2016-0004"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00428-018-2384-3","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T13:59:03Z","timestamp":1527861543000},"page":"453-462","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein"],"prefix":"10.1007","volume":"473","author":[{"given":"Ambrus","family":"G\u00e1ng\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bence","family":"B\u00e1tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f3ra","family":"Kapcz\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerg\u0151","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rta","family":"Marschalk\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enik\u0151","family":"Kuroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Csomor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"Matolcsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"B\u00f6d\u00f6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gota","family":"Szepesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"issue":"1","key":"2384_CR1","first-page":"354","volume":"90","author":"R Willemze","year":"1997","unstructured":"Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJ (1997) EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study Group of the European Organization for Research and Treatment of Cancer. Blood 90(1):354\u2013371","journal-title":"Blood"},{"issue":"12","key":"2384_CR2","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1001\/archderm.143.12.1520","volume":"143","author":"NJ Senff","year":"2007","unstructured":"Senff NJ, Hoefnagel JJ, Neelis KJ, Vermeer MH, Noordijk EM, Willemze R (2007) Results of radiotherapy in 153 primary cutaneous B-cell lymphomas classified according to the WHO-EORTC classification. Arch Dermatol 143(12):1520\u20131526. \n                    https:\/\/doi.org\/10.1001\/archderm.143.12.1520","journal-title":"Arch Dermatol"},{"issue":"10","key":"2384_CR3","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","volume":"105","author":"R Willemze","year":"2005","unstructured":"Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105(10):3768\u20133785. \n                    https:\/\/doi.org\/10.1182\/blood-2004-09-3502","journal-title":"Blood"},{"issue":"6","key":"2384_CR4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/00000478-200206000-00006","volume":"26","author":"JR Goodlad","year":"2002","unstructured":"Goodlad JR, Krajewski AS, Batstone PJ, McKay P, White JM, Benton EC, Kavanagh GM, Lucraft HH (2002) Primary cutaneous follicular lymphoma: a clinicopathologic and molecular study of 16 cases in support of a distinct entity. Am J Surg Pathol 26(6):733\u2013741. \n                    https:\/\/doi.org\/10.1097\/00000478-200206000-00006","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2384_CR5","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/01.pas.0000126775.27698.6e","volume":"28","author":"B Vergier","year":"2004","unstructured":"Vergier B, Belaud-Rotureau MA, Benassy MN, Beylot-Barry M, Dubus P, Delaunay M, Garroste JC, Taine L, Merlio JP (2004) Neoplastic cells do not carry bcl2-JH rearrangements detected in a subset of primary cutaneous follicle center B-cell lymphomas. Am J Surg Pathol 28(6):748\u2013755. \n                    https:\/\/doi.org\/10.1097\/01.pas.0000126775.27698.6e","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2384_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/01.pas.0000146015.22624.c7","volume":"29","author":"BK Kim","year":"2005","unstructured":"Kim BK, Surti U, Pandya A, Cohen J, Rabkin MS, Swerdlow SH (2005) Clinicopathologic, immunophenotypic, and molecular cytogenetic fluorescence in situ hybridization analysis of primary and secondary cutaneous follicular lymphomas. Am J Surg Pathol 29(1):69\u201382. \n                    https:\/\/doi.org\/10.1097\/01.pas.0000146015.22624.c7","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2384_CR7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/00000478-200604000-00015","volume":"30","author":"B Streubel","year":"2006","unstructured":"Streubel B, Scheucher B, Valencak J, Huber D, Petzelbauer P, Trautinger F, Weihsengruber F, Mannhalter C, Cerroni L, Chott A (2006) Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas. Am J Surg Pathol 30(4):529\u2013536. \n                    https:\/\/doi.org\/10.1097\/00000478-200604000-00015","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"2384_CR8","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.jaad.2014.01.862","volume":"70","author":"A Abdul-Wahab","year":"2014","unstructured":"Abdul-Wahab A, Tang SY, Robson A, Morris S, Agar N, Wain EM, Child F, Scarisbrick J, Neat M, Whittaker S (2014) Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis. J Am Acad Dermatol 70(6):1010\u20131020. \n                    https:\/\/doi.org\/10.1016\/j.jaad.2014.01.862","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"2384_CR9","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1002\/cam4.865","volume":"5","author":"M Lucioni","year":"2016","unstructured":"Lucioni M, Berti E, Arcaini L, Croci GA, Maffi A, Klersy C, Goteri G, Tomasini C, Quaglino P, Riboni R, Arra M, Dallera E, Grandi V, Alaibac M, Ramponi A, Rattotti S, Cabras MG, Franceschetti S, Fraternali-Orcioni G, Zerbinati N, Onida F, Ascani S, Fierro MT, Rupoli S, Gambacorta M, Zinzani PL, Pimpinelli N, Santucci M, Paulli M (2016) Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: comparison with current classification and definition of prognostic markers. Cancer Med 5(10):2740\u20132755. \n                    https:\/\/doi.org\/10.1002\/cam4.865","journal-title":"Cancer Med"},{"issue":"4","key":"2384_CR10","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/his.13279","volume":"71","author":"E Verdanet","year":"2017","unstructured":"Verdanet E, Dereure O, Rene C, Tempier A, Benammar-Hafidi A, Gallo M, Frouin E, Durand L, Gazagne I, Costes-Martineau V, Cacheux V, Szablewski V (2017) Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas. Histopathology 71(4):648\u2013660. \n                    https:\/\/doi.org\/10.1111\/his.13279","journal-title":"Histopathology"},{"issue":"3","key":"2384_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/leu.2011.266","volume":"26","author":"E Launay","year":"2012","unstructured":"Launay E, Pangault C, Bertrand P, Jardin F, Lamy T, Tilly H, Tarte K, Bastard C, Fest T (2012) High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis. Leukemia 26(3):559\u2013562. \n                    https:\/\/doi.org\/10.1038\/leu.2011.266","journal-title":"Leukemia"},{"issue":"11","key":"2384_CR12","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1182\/blood-2013-05-500595","volume":"123","author":"A Bouska","year":"2014","unstructured":"Bouska A, McKeithan TW, Deffenbacher KE, Lachel C, Wright GW, Iqbal J, Smith LM, Zhang W, Kucuk C, Rinaldi A, Bertoni F, Fitzgibbon J, Fu K, Weisenburger DD, Greiner TC, Dave BJ, Gascoyne RD, Rosenwald A, Ott G, Campo E, Rimsza LM, Delabie J, Jaffe ES, Braziel RM, Connors JM, Staudt LM, Chan WC (2014) Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma. Blood 123(11):1681\u20131690. \n                    https:\/\/doi.org\/10.1182\/blood-2013-05-500595","journal-title":"Blood"},{"issue":"2","key":"2384_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ng.518","volume":"42","author":"RD Morin","year":"2010","unstructured":"Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R, Paul JE, Boyle M, Woolcock BW, Kuchenbauer F, Yap D, Humphries RK, Griffith OL, Shah S, Zhu H, Kimbara M, Shashkin P, Charlot JF, Tcherpakov M, Corbett R, Tam A, Varhol R, Smailus D, Moksa M, Zhao Y, Delaney A, Qian H, Birol I, Schein J, Moore R, Holt R, Horsman DE, Connors JM, Jones S, Aparicio S, Hirst M, Gascoyne RD, Marra MA (2010) Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 42(2):181\u2013185. \n                    https:\/\/doi.org\/10.1038\/ng.518","journal-title":"Nat Genet"},{"key":"2384_CR14","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised 4h Edition","author":"SH Swerdlow","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (2017) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised 4h Edition, vol 2, 4th edn. IARC press, Lyon","edition":"4"},{"issue":"10","key":"2384_CR15","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1038\/leu.2012.246","volume":"26","author":"AW Langerak","year":"2012","unstructured":"Langerak AW, Groenen P, Br\u00fcggemann M, Beldjord K, Bellan C, Bonello L, Boone E, Carter GI, Catherwood M, Davi F, Delfau-Larue M, Diss T, Evans PAS, Gameiro P, Garcia Sanz R, Gonzalez D, Grand D, H\u00e5kansson \u00c5, Hummel M, Liu H, Lombardia L, Macintyre EA, Milner BJ, Montes-Moreno S, Schuuring E, Spaargaren M, Hodges E, van Dongen JJM (2012) EuroClonality\/BIOMED-2 guidelines for interpretation and reporting of Ig\/TCR clonality testing in suspected lymphoproliferations. Leukemia 26(10):2159\u20132171. \n                    https:\/\/doi.org\/10.1038\/leu.2012.246","journal-title":"Leukemia"},{"issue":"4","key":"2384_CR16","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s12253-017-0200-z","volume":"23","author":"G Papp","year":"2017","unstructured":"Papp G, Mihaly D, Sapi Z (2017) Unusual signal patterns of break-apart FISH probes used in the diagnosis of soft tissue sarcomas. Pathology oncology research : POR 23(4):863\u2013871. \n                    https:\/\/doi.org\/10.1007\/s12253-017-0200-z","journal-title":"Pathology oncology research : POR"},{"issue":"2","key":"2384_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","volume":"110","author":"YH Kim","year":"2007","unstructured":"Kim YH, Willemze R, Pimpinelli N, Whittaker S, Olsen EA, Ranki A, Dummer R, Hoppe RT (2007) TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110(2):479\u2013484. \n                    https:\/\/doi.org\/10.1182\/blood-2006-10-054601","journal-title":"Blood"},{"issue":"22","key":"2384_CR18","doi-asserted-by":"publisher","first-page":"9166","DOI":"10.1158\/0008-5472.CAN-10-2460","volume":"70","author":"KJ Cheung","year":"2010","unstructured":"Cheung KJ, Johnson NA, Affleck JG, Severson T, Steidl C, Ben-Neriah S, Schein J, Morin RD, Moore R, Shah SP, Qian H, Paul JE, Telenius A, Relander T, Lam W, Savage K, Connors JM, Brown C, Marra MA, Gascoyne RD, Horsman DE (2010) Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis. Cancer Res 70(22):9166\u20139174. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2460","journal-title":"Cancer Res"},{"issue":"1","key":"2384_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/pas.0000000000000567","volume":"40","author":"V Szablewski","year":"2016","unstructured":"Szablewski V, Ingen-Housz-Oro S, Baia M, Delfau-Larue MH, Copie-Bergman C, Ortonne N (2016) Primary cutaneous follicle center lymphomas expressing BCL2 protein frequently harbor BCL2 gene break and may present 1p36 deletion: a study of 20 cases. Am J Surg Pathol 40(1):127\u2013136. \n                    https:\/\/doi.org\/10.1097\/pas.0000000000000567","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2384_CR20","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","volume":"113","author":"T Katzenberger","year":"2009","unstructured":"Katzenberger T, Kalla J, Leich E, Stocklein H, Hartmann E, Barnickel S, Wessendorf S, Ott MM, Muller-Hermelink HK, Rosenwald A, Ott G (2009) A distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36. Blood 113(5):1053\u20131061. \n                    https:\/\/doi.org\/10.1182\/blood-2008-07-168682","journal-title":"Blood"},{"issue":"8","key":"2384_CR21","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1182\/blood-2016-03-703819","volume":"128","author":"J Schmidt","year":"2016","unstructured":"Schmidt J, Gong S, Marafioti T, Mankel B, Gonzalez-Farre B, Balague O, Mozos A, Cabecadas J, van der Walt J, Hoehn D, Rosenwald A, Ott G, Dojcinov S, Egan C, Nadeu F, Ramis-Zaldivar JE, Clot G, Barcena C, Perez-Alonso V, Endris V, Penzel R, Lome-Maldonado C, Bonzheim I, Fend F, Campo E, Jaffe ES, Salaverria I, Quintanilla-Martinez L (2016) Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene. Blood 128(8):1101\u20131111. \n                    https:\/\/doi.org\/10.1182\/blood-2016-03-703819","journal-title":"Blood"},{"issue":"3","key":"2384_CR22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1309\/ajcp4subr4npsptn","volume":"143","author":"A Pham-Ledard","year":"2015","unstructured":"Pham-Ledard A, Cowppli-Bony A, Doussau A, Prochazkova-Carlotti M, Laharanne E, Jouary T, Belaud-Rotureau MA, Vergier B, Merlio JP, Beylot-Barry M (2015) Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions. Am J Clin Pathol 143(3):362\u2013373. \n                    https:\/\/doi.org\/10.1309\/ajcp4subr4npsptn","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"2384_CR23","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1309\/2tju-dnlq-5jba-ab4t","volume":"118","author":"LC Lawnicki","year":"2002","unstructured":"Lawnicki LC, Weisenburger DD, Aoun P, Chan WC, Wickert RS, Greiner TC (2002) The t(14;18) and bcl-2 expression are present in a subset of primary cutaneous follicular lymphoma: association with lower grade. Am J Clin Pathol 118(5):765\u2013772. \n                    https:\/\/doi.org\/10.1309\/2tju-dnlq-5jba-ab4t","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"2384_CR24","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1038\/sj.leu.2403175","volume":"17","author":"RT Costello","year":"2003","unstructured":"Costello RT, Mallet F, Barbarat B, Schiano De Colella JM, Sainty D, Sweet RW, Truneh A, Olive D (2003) Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicity. Leukemia 17(12):2500\u20132507. \n                    https:\/\/doi.org\/10.1038\/sj.leu.2403175","journal-title":"Leukemia"},{"issue":"42","key":"2384_CR25","doi-asserted-by":"publisher","first-page":"27548","DOI":"10.1074\/jbc.273.42.27548","volume":"273","author":"JA Harrop","year":"1998","unstructured":"Harrop JA, McDonnell PC, Brigham-Burke M, Lyn SD, Minton J, Tan KB, Dede K, Spampanato J, Silverman C, Hensley P, DiPrinzio R, Emery JG, Deen K, Eichman C, Chabot-Fletcher M, Truneh A, Young PR (1998) Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM\/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J Biol Chem 273(42):27548\u201327556. \n                    https:\/\/doi.org\/10.1074\/jbc.273.42.27548","journal-title":"J Biol Chem"},{"issue":"12","key":"2384_CR26","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1182\/blood.V97.12.3896","volume":"97","author":"FJ Kemenade van","year":"2001","unstructured":"van Kemenade FJ, Raaphorst FM, Blokzijl T, Fieret E, Hamer KM, Satijn DP, Otte AP, Meijer CJ (2001) Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood 97(12):3896\u20133901. \n                    https:\/\/doi.org\/10.1182\/blood.V97.12.3896","journal-title":"Blood"},{"issue":"10","key":"2384_CR27","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.3109\/10428194.2015.1006220","volume":"56","author":"Z Zhou","year":"2015","unstructured":"Zhou Z, Gao J, Popovic R, Wolniak K, Parimi V, Winter JN, Licht JD, Chen YH (2015) Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutation. Leuk Lymphoma 56(10):2895\u20132901. \n                    https:\/\/doi.org\/10.3109\/10428194.2015.1006220","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"2384_CR28","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.3109\/10428194.2014.968780","volume":"56","author":"M Shi","year":"2015","unstructured":"Shi M, Shahsafaei A, Liu C, Yu H, Dorfman DM (2015) Enhancer of zeste homolog 2 is widely expressed in T-cell neoplasms, is associated with high proliferation rate and correlates with MYC and pSTAT3 expression in a subset of cases. Leuk Lymphoma 56(7):2087\u20132091. \n                    https:\/\/doi.org\/10.3109\/10428194.2014.968780","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"2384_CR29","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.3109\/10428194.2013.858816","volume":"55","author":"HJ Lee","year":"2014","unstructured":"Lee HJ, Shin DH, Kim KB, Shin N, Park WY, Lee JH, Choi KU, Kim JY, Lee CH, Sol MY (2014) Polycomb protein EZH2 expression in diffuse large B-cell lymphoma is associated with better prognosis in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. Leuk Lymphoma 55(9):2056\u20132063. \n                    https:\/\/doi.org\/10.3109\/10428194.2013.858816","journal-title":"Leuk Lymphoma"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-018-2384-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-018-2384-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-018-2384-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T02:50:53Z","timestamp":1559357453000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-018-2384-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["2384"],"URL":"https:\/\/doi.org\/10.1007\/s00428-018-2384-3","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]},"assertion":[{"value":"11 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All protocols were approved by the Institutional Ethical Review Board (TUKEB no. 7\/2006).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}